Just metabolically magnificent."
It's important to note that not all patients will require electrolyte supplementation this is primarily indicated for those experiencing significant gastrointestinal losses or inadequate intake, rather than as routine for all GLP-1 users
She was awesome
Why Dermatologists Are Concerned The Skin Cancer Foundation recently spoke out about the growing use of Melanotan II, with its president publicly discouraging the use of it and similar unapproved tanning agents marketed as shortcuts to darker skin
How membrane-active peptides get into lipid membranes
MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID
